JINYU(SH:600201)2016-04-26 16:00Financial Performance - Operating income for the period was CNY 342,574,317.20, reflecting a growth of 1.74% year-on-year[6] - Net profit attributable to shareholders reached CNY 190,503,251.87, up 14.72% from the previous year[6] - Basic earnings per share increased by 13.33% to CNY 0.34[6] - The total profit for Q1 2016 was CNY 227,008,069.25, compared to CNY 197,992,358.09 in the previous year, marking a growth of 14.5%[28] - The net profit for Q1 2016 was CNY 191,098,217.05, representing a 15.0% increase from CNY 166,158,790.91 in Q1 2015[28] - The company's operating revenue for Q1 2016 was CNY 2,053,004.19, an increase of 37.7% compared to CNY 1,491,324.41 in the same period last year[30] Cash Flow - Cash flow from operating activities surged by 1,343.60% to CNY 95,565,230.80 compared to the same period last year[6] - The company reported a net cash inflow from operating activities of CNY 95,565,230.80, significantly higher than CNY 6,619,947.07 in Q1 2015[33] - The cash and cash equivalents at the end of Q1 2016 totaled CNY 1,146,334,127.22, an increase from CNY 897,888,893.04 at the end of Q1 2015[33] - The cash inflow from sales of goods and services was ¥7,305,577.65, compared to ¥6,301,915.34 in the previous period, marking an increase of approximately 15.9%[35] - Total cash inflow from operating activities reached ¥161,705,923.91, compared to ¥114,931,340.40 in the prior period, indicating an increase of about 40.7%[35] Assets and Liabilities - Total assets increased by 8.74% to CNY 2,773,205,014.55 compared to the end of the previous year[6] - Total liabilities rose to ¥510,589,415.47 compared to ¥481,624,136.55, an increase of about 6.5%[21] - Total equity attributable to shareholders increased to ¥2,263,184,702.16 from ¥2,068,789,589.62, reflecting a growth of approximately 9.4%[22] - The total current assets as of March 31, 2016, amounted to approximately 1.78 billion RMB, compared to 1.54 billion RMB at the beginning of the year[20] Shareholder Information - The total number of shareholders reached 18,478 by the end of the reporting period[10] - The largest shareholder, Inner Mongolia Agricultural and Animal Husbandry Pharmaceutical Co., Ltd., holds 67,200,000 shares, accounting for 11.73% of total shares[10] Operating Costs and Expenses - Operating costs decreased by 25.44 million RMB, a reduction of 26.64%, mainly due to reduced technical commission provisions in the biopharmaceutical sector[12] - The total operating expenses for Q1 2016 were CNY 2,652,624.75, compared to CNY 2,347,113.77 in Q1 2015, reflecting an increase of 12.9%[30] - The financial expenses for Q1 2016 were CNY -3,181,676.79, compared to CNY -2,156,874.89 in Q1 2015, indicating a higher cost of financing[30] Other Financial Metrics - The company reported a net non-operating income of CNY 970,260.67 for the period[9] - The weighted average return on equity decreased by 0.86 percentage points to 8.85%[6] - The company recorded an investment income of CNY 266,637.79 in Q1 2016, recovering from a loss of CNY 31,198.83 in the same period last year[30] - The company maintained a stable capital reserve of ¥52,588,230.61, up from ¥49,666,630.61, reflecting an increase of about 5.8%[22] Receivables and Deferred Income - Accounts receivable increased by 91.15 million RMB, a rise of 36.66%, primarily due to year-end government procurement payments in the biopharmaceutical sector[12] - Other receivables increased by 16.75 million RMB, a significant increase of 233.46%, mainly due to increased transactions in the biopharmaceutical sector[12] - Deferred income rose by 29.23 million RMB, an increase of 64.24%, primarily from government subsidies received for the Jinyu Industrial Park[12] - Deferred income increased to ¥74,717,950.00 from ¥45,492,950.00, representing a growth of approximately 64.2%[21]